| Market Capitalization (Millions $) |
3 |
| Shares
Outstanding (Millions) |
0 |
| Employees |
11 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-15 |
| Cash Flow (TTM) (Millions $) |
-3 |
| Capital Exp. (TTM) (Millions $) |
0 |
Transcode Therapeutics Inc
Transcode Therapeutics Inc is a biopharmaceutical company that specializes in the development of innovative RNA therapeutics. They focus on creating cutting-edge treatments for various diseases by harnessing the power of mRNA and related technologies.
Transcode Therapeutics utilizes its proprietary platform to design and optimize novel RNA therapeutics, including mRNA vaccines, mRNA-based gene therapies, and RNAi therapeutics. Their approach allows for precise targeting and modulation of disease-causing genes and proteins, offering potential solutions for a wide range of medical conditions.
The company aims to revolutionize the field of medicine by leveraging the versatility of RNA molecules to develop safe and effective therapies. Through their research and development efforts, Transcode Therapeutics is dedicated to advancing the understanding and application of RNA in the treatment of diseases, ultimately improving patient outcomes and quality of life.
Company Address: 6 Liberty Square, #2382 Boston 2109 MA
Company Phone Number: 837-3099 Stock Exchange / Ticker: NASDAQ RNAZ
|
1.21%